濮阳东方医院男科治早泄值得选择濮阳东方医院看早泄口碑很好价格低,濮阳东方妇科医院做人流怎么样,濮阳东方男科医院割包皮口碑好很放心,濮阳东方医院治疗早泄收费不贵,濮阳东方男科网上挂号,濮阳东方妇科医院价格收费低,濮阳东方医院治早泄技术专业

We've all experienced someone speeding through our neighborhood. But would drivers actually slow down if the city were to lower the speed limit?According to a new study by the Insurance Institute for Highway Safety, it would. The study was done on the streets of Boston, and it found that lowering the default speed limit from 30 to 25 reduced the odds of a vehicle going over 35 miles per hour by about 30 percent.The study also found the odds of exceeding 30 mph fell by over 8 percent, and the odds someone would exceed 25 mph fell by almost 3 percent.The study did not examine how the lower speed limits affected crashes, but the institute plans to study that in their next phase.The authors of the study also say that the number of deaths related to speeding were actually higher on roads where the speed limit is 35 mph or lower, than it is on roadways where cars are going much faster. 900

When Christina and Tarek El Moussa announced in late 2016 they were ending their marriage after seven years, fans worried it would mean an end to their wildly popular HGTV series, "Flip or Flop."The series continued, even as the couple divorced, but news that Christina was branching out with a new show again stirred concerns that "Flip or Flop" would soon end.Well, worry no more: Christina announced Wednesday that the show is definitely still on."We're baaacckkk!!! #FlipOrFlop was just picked up by @hgtv for 15 new episodes!!" read the caption on a video she posted of her and her ex on Instagram. "Look for Season 8 to premiere in Spring 2019."The pair, who have a young son and daughter, released a statement at the time of their split."Like many couples, we have had challenges in our marriage," they said. "We had an unfortunate misunderstanding about six months ago and the police were called to our house in an abundance of caution. There was no violence and no charges were filed."They also said they were planning to focus on their children and continue to work together.HGTV execs said they were fully supportive of however the former couple planned to handle it."When it comes to matters related to their own family, we respect their privacy and honor any decision that works best for them and their children," the network said in a statement provided to CNN. "HGTV is currently airing episodes of 'Flip or Flop' and the series will continue production as scheduled."In the video posted Wednesday, Tarek El Moussa sounded just as stoked as his ex-wife that the eighth season was happening."I know we've been around for a really, really long time, but we are back," he said. "We're ready to flip some houses!" 1732

What you flush down your toilet could be brought back up to detect COVID-19.“Anytime that we are talking about poop, it’s a subject that either brings laughter or disgust; maybe a combination of the two,” said John Putnam with Colorado Public Health and Environment. Putnam is helping lead a team to test human waste to determine molecule levels linked with the coronavirus.“This gives you early warning that there could be an upsurge or a lessening of the disease in the community,” he said.Putnam says a person that’s been exposed to COVID-19 will pass the virus through their feces and possibly even urine. The waste eventually flows into sewer systems, which scientists will now collect.“We can then take a sample at a wastewater plant and send it to a lab,” he said.Labs at places like Metropolitan State University of Denver.“One of the advantages of this approach is that everybody in the community makes a contribution to the sewage,” said Rebecca Ferrell, Ph.D., a biology professor at MSU Denver.She says that when people get infected with COVID-19, they often shed the virus for several days before showing symptoms. Adding that this specialized stool sampling can alert scientists that the virus is in a community before people start getting sick.“It can give you extra warning about what might be happening in the hospitals then days maybe even a week later when people get sick enough that they are going to make demands on health care that you need to anticipate,” Ferrell said.With the cost to collect this data much cheaper than other options, Ferrell says more scientists are now teaming up with more wastewater treatment plants across the country.“These are the kinds of techniques where a relatively small investment early on can help us to get those resources to the right place and we can keep the mortality low,” she said.Hoping to get ahead of the pandemic, testing number two is becoming the number one priority for some scientists. 1965

With a coronavirus vaccine still months off, companies are rushing to test what may be the next best thing: drugs that deliver antibodies to fight the virus right away, without having to train the immune system to make them.Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated. Vaccines work by tricking the body into thinking there’s an infection so it makes antibodies and remembers how to do that if the real bug turns up.But it can take a month or two after vaccination or infection for the most effective antibodies to form. The experimental drugs shortcut that process by giving concentrated versions of specific ones that worked best against the coronavirus in lab and animal tests.“A vaccine takes time to work, to force the development of antibodies. But when you give an antibody, you get immediate protection,” said University of North Carolina virologist Dr. Myron Cohen. “If we can generate them in large concentrations, in big vats in an antibody factory ... we can kind of bypass the immune system.”These drugs are believed to last for a month or more and could give quick, temporary immunity to people at high risk of infection, such as health workers and housemates of someone with COVID-19. If they proved effective and if a vaccine doesn’t materialize or protect as hoped, the drugs might eventually be considered for wider use, perhaps for teachers or other groups.They’re also being tested as treatments, to help the immune system and prevent severe symptoms or death.“The hope there is to target people who are in the first week of their illness and that we can treat them with the antibody and prevent them from getting sick,” said Dr. Marshall Lyon, an infectious disease specialist helping to test one such drug at Emory University in Atlanta.Having such a tool “would be a really momentous thing in our fight against COVID,” Cohen said.Vaccines are seen as a key to controlling the virus, which has been confirmed to have infected more than 20 million people worldwide and killed more than 738,000. Several companies are racing to develop vaccines, but the results of the large final tests needed to evaluate them are months away.The antibody drugs are “very promising” and, in contrast, could be available “fairly soon,” said Dr. Janet Woodcock, a U.S. Food and Drug Administration official who is leading government efforts to speed COVID-19 therapies. Key studies are underway and some answers should come by early fall.One company, Eli Lilly, has already started manufacturing its antibody drug, betting that studies now underway will give positive results.“Our goal is to get something out as soon as possible” and to have hundreds of thousands of doses ready by fall, said Lilly’s chief scientific officer, Dr. Daniel Skovronsky.Another company that developed an antibody drug cocktail against Ebola — Regeneron Pharmaceuticals Inc. — now is testing one for coronavirus.“The success with our Ebola program gives us some confidence that we can potentially do this again,” said Christos Kyratsous, a Regeneron microbiologist who helped lead that work.Regeneron’s drug uses two antibodies to enhance chances the drug will work even if the virus evolves to evade action by one.Lilly is testing two different, single-antibody drugs — one with the Canadian company AbCellera and another with a Chinese company, Junshi Biosciences. In July, Junshi said no safety concerns emerged in 40 healthy people who tried it and that larger studies were getting underway.Others working on antibody drugs include Amgen and Adaptive Biotechnologies. The Singapore biotech company Tychan Pte Ltd. also is testing an antibody drug and has similar products in development for Zika virus and yellow fever.“I’m cautiously optimistic” about the drugs, said the nation’s top infectious diseases expert, Dr. Anthony Fauci. “I’m heartened by the experience that we had with Ebola,” where the drugs proved effective.What could go wrong?— The antibodies may not reach all of the places in the body where they need to act, such as deep in the lungs. All the antibody drugs are given through an IV and must make their way through the bloodstream to wherever they’re needed.— The virus might mutate to avoid the antibody — the reason Regeneron is testing a two-antibody combo that binds to the virus in different places to help prevent its escape.Skovronsky said Lilly stuck with one antibody because manufacturing capacity would essentially be cut in half to make two, and “you will have less doses available.” If a single antibody works, “we can treat twice as many people,” he said.— The antibodies might not last long enough. If they fade within a month, it’s still OK for treatment since COVID-19 illness usually resolves in that time. But for prevention, it may not be practical to give infusions more often than every month or two.A San Francisco company, Vir Biotechnology Inc., says it has engineered antibodies to last longer than they usually do to avoid this problem. GlaxoSmithKline has invested 0 million in Vir to test them.Giving a higher dose also may help. If half of antibodies disappear after a month, “if you give twice as much, you will have two months’ protection,” Lilly’s Skovronsky said.— The big fear: Antibodies may do the opposite of what’s hoped and actually enhance the virus’s ability to get into cells or stimulate the immune system in a way that makes people sicker. It’s a theoretical concern that hasn’t been seen in testing so far, but large, definitive experiments are needed to prove safety.“As best as we can tell, the antibodies are helpful,” Lyon said.___Marilynn Marchione can be followed on Twitter: @MMarchioneAP___The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. 5919

While many Americans do it, taking a selfie with a completed ballot is considered a crime in most states. According to CNN, there are laws prohibiting taking or distributing photos of your ballot while at the polls in 27 states. For voters in 23 states and DC, photos from the voting booth are generally permissible. A person could be charged with a felony in Illinois and Wisconsin for taking photos at the ballot booth.While some of the 23 states have previously had laws prohibiting photography of ballots, there have been recent court rulings questioning the constitutionality of such laws. One example came during 2016 in New Hampshire. The state argued that the law was necessary to prevent ballot photography to be used as a means of voter fraud or intimidation. The plaintiffs argued that prohibiting ballot photography denied voters their free speech rights. A federal appeals court ruled 3-0 that the state had not shown that it was using the least restrictive means to achieve a compelling state interest of prohibiting voting fraud. According to the ruling, New Hampshire Secretary of State William Gardner was unable to show examples of how ballot photography led to voting fraud. "The restriction affects voters who are engaged in core political speech, an area highly protected by the First Amendment," the ruling states. "There is an increased use of social media and ballot selfies in particular in service of political speech by voters. A ban on ballot selfies would suppress a large swath of political speech."Indiana also had a law passed in 2015 that would have made ballot selfies a felony struck down by a federal judge.In Colorado, the state made it legal in 2017 to take ballot pictures. But in Alabama, Arizona, Florida, Georgia, Illinois, Iowa, Maryland, Michigan, Nevada, New Jersey, New York, North Carolina, Ohio, South Carolina, South Dakota, Tennessee, Texas and West Virginia, it is illegal to take photos at the polling place, according to CNN. In Alaska, Louisiana, Massachusets, Minnesota, Mississippi, Missouri, Oklahoma, Utah and Vermont, pictures at the ballot box are okay, but cannot include a photo of a completed ballot.  To see a state-by-state breakdown of the laws regulating ballot selfies, click here.  2343